Top U.S. Hospitals for Heart Care

ANN ARBOR, Mich., Nov. 14, 2011 /Coal Geology-PRNewswire/ — Thomson Reuters today released its annual study identifying the top U.S. hospitals for inpatient cardiovascular services. The study, in its thirteenth year, singled out 50 hospitals that achieved superior clinical outcomes. “This year’s 50 Top Cardiovascular Hospitals have continued to deliver excellent care and have been able to…

Paid sick days would decrease unnecessary emergency department use

WASHINGTON, Nov. 14, 2011 /Coal Geology-PRNewswire-USNewswire/ — Access to paid sick days could save $1 billion in medical costs annually according to a report released today by the Institute for Women’s Policy Research (IWPR). This includes $500 million in taxpayer-funded public health care programs for children, elders, and low-income Americans. Currently, more than 44 million American workers do not have access to paid sick days,…

Correlation between environmental factors such as weather and increased stroke incidence

July 25, 2011, COLORADO SPRINGS, Colo.,(Coal Geology) – Study results released today at the Society of NeuroInterventional Surgery (SNIS) 8th Annual Meeting revealed a correlation between lower temperatures and increased hospital admissions for ischemic stroke and transient ischemic attack (TIA), commonly known as a mini-stroke, in an east coast city population. As one of the…

University of Michigan Hospitals and Health Centers Receives Top Environmental Award

April 11, 2011, ANN ARBOR, Mich., (Coal Geology) – For the fifth consecutive year, the University of Michigan Hospitals and Health Centers has been given the Environmental Leadership Circle Award, Practice Greenhealth’s most prestigious honor. Practice Greenhealth, a national membership organization of health care facilities committed to environmentally responsible operations, presented the award in Phoenix…

FDA Allows Enrollment of Up to 20 Additional Patients and Two New Trial Sites

April 10, 2011, MINNEAPOLIS, MN (Coal Geology)- Sunshine Heart, Inc. (ASX: SHC), a global medical device company focused on innovative technologies for Class III/ambulatory Class IV (moderate to severe) heart failure, today announced that the United States Food and Drug Administration (FDA) has approved the Company’s investigational device exemption (IDE) supplement for the C-Pulse® Heart…